Experienced in Neuroendocrine Tumor

Taiba Zornitzki

Bilu Street 1, 
Rehovot, M, IL 
Experienced in Neuroendocrine Tumor
Bilu Street 1, 
Rehovot, M, IL 
OverviewLocationsClinical Research

Overview

Taiba Zornitzki practices in Rehovot, Israel. Ms. Zornitzki is rated as an Experienced expert by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Type 2 Diabetes (T2D), Subacute Thyroiditis, Thyroid Nodule, Hypothyroidism, and Gastric Bypass.

Her clinical research consists of co-authoring 33 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Neuroendocrine Tumor.

Gender
Female

Locations

Bilu Street 1, Rehovot, M 76100, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

33 Total Publications

Risk Stratification and Long-Term Outcome of Benign Thyroid Nodules - An 11-Year Cohort Study.
Risk Stratification and Long-Term Outcome of Benign Thyroid Nodules - An 11-Year Cohort Study.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: April 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Zornitzki's expertise for a condition
ConditionClose
        View All 20 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile